Several possible studies
Story checked
Ivermectin (oral route) - Side effects & dosage - Mayo Clinic (opens in a new tab)
mayoclinic.org · 2026-02-01
Short answer
Several possible studiesStudy not confirmed.
Several potential source studies were identified, but no single match could be confirmed. The article's claims remain unverified.
These papers were considered as possible sources, but none could be confirmed as the study behind this story.
Share this check
The story
Ivermectin (oral route) - Side effects & dosage - Mayo Clinic
mayoclinic.org · 2026-02-01
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Multiple potential source studies identified.
Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.
View article claimsSearch result
Several studies could fit.
Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.
Evidence layer
Claim by claim
The article's claims are listed below. Without a confirmed source study, they have not been assessed as supported or unsupported.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 4Not checkedIvermectin is used to treat river blindness (onchocerciasis), intestinal infection from threadworms (strongyloidiasis), and other kinds of worm infections.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 2 of 4Not checkedIvermectin is an anthelmintic that works by interfering with the nerve and muscle functions of worms, paralyzing and killing them.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 3 of 4Not checkedThe monograph says dosing depends on the condition and body weight, with treatment sometimes repeated every 3 to 12 months, and that children weighing less than 15 kg require doctor-directed dosing.View evidenceHide evidence
As stated150 mcg/kg for river blindness; 200 mcg/kg for threadworms; repeat every 3 to 12 months in some cases
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 4 of 4Not checkedThe article warns that ivermectin may cause serious eye, skin, brain, and nerve reactions, and lists asthma as a condition requiring caution.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Method layer
Study not confirmed.
The search results are available for you to inspect. Without a confirmed source study, they cannot establish whether the story’s claims are supported or contradicted.
Search results
Candidate papers, not confirmed sources.
PubMed, Europe PMC, Crossref · 15 candidate papers
Ivermectin and gynecologic cancer: What's the data?
Gynecologic Oncology Reports · 2025 · PubMed, Europe PMC
Death to Onchocerciasis and Lymphatic Filariasis: Comparison of Ivermectin alone with Albendazole (ALB) plus Ivermectin (IVM) in their efficacy against Onchocerciasis
Http://isrctn.org/> · 2012 · Crossref
Access to essential drugs for neglected tropical diseases in Italy: the case of Ivermectin.
2025 · Europe PMC
Efficacy and safety of ascending doses of emodepside in comparison with ivermectin in adults infected with Strongyloides stercoralis in Laos: a phase 2a, dose-ranging, randomised, parallel-group, placebo-controlled, single-blind clinical trial.
The Lancet. Infectious Diseases · 2025 · PubMed
IVERMECTIN IN ONCHOCERCIASIS
The Lancet · 1984 · Crossref